4
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001415889-24-028203
President and CEO sold 15,000 shares at $67.00 ($1,005,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Campbell David Alan · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-03 | Sale : show line 1 in the form 10b5-1 | −15,000 | $67.00 | $1,005,000 | 242,054 | D |
| Open-market sales · 15,000 sh · avg $67.00 · $1,005,000 | ||||||
Loading xslF345X05/form4-12032024_081201.xml…